Navigation Links
HPV testing: IQWiG still sees indications of a benefit in primary screening
Date:6/11/2014

screening round was lower in the HPV group than in the group of women who had only been examined with a cytology-based screening strategy (e.g. Pap smear) in the first screening round. This also applies to the so-called "composite outcome", which not only comprised tumours, but also advanced precursors of cancer. IQWiG therefore determined an indication of a benefit in each case.

There are still no data or no evaluable data available on mortality, quality of life and potential harm.

As the screening strategies applied in the studies varied greatly and could therefore not be compared with each other, the results still do not allow a recommendation for a specific screening strategy in the German health care system.

Process of report production

The Federal Joint Committee (G-BA) commissioned IQWiG to prepare the report in an accelerated process, known as a "rapid report". Unlike the normal procedure, no preliminary reports are published in this case. Although a draft version of the report is reviewed by external experts, no hearing at which all interested parties can comment takes place.

IQWiG sent the first benefit assessment to the commissioning agency in November 2011 and published it in January 2012. In October, the G-BA commissioned IQWiG to update its report using the same methodological approach. The present report was sent to the G-BA in mid-May 2014.


'/>"/>
Contact: Dr. Anna-Sabine Ernst
presse@iqwig.de
49-022-135-6850
Institute for Quality and Efficiency in Health Care
Source:Eurekalert

Page: 1 2

Related medicine news :

1. HIV self-testing: The key to controlling the global epidemic
2. IQWiG: First health economic evaluation completed
3. IQWiG publishes new version of its General Methods
4. Men Can Still Ask for PSA Test, and Some Should, Doctors Say
5. Fewer Stillbirths Among Pregnant Women Vaccinated Against Flu
6. Many Still Tanning, Despite Dangers, Survey Finds
7. Once-Obese Women Still Face Stigma, Study Finds
8. Smallest, Largest Fetuses at Higher Risk of Stillbirth
9. People With Darker Skin Still at Risk for Melanoma
10. In-Person Bullying Still Bigger Problem Than Cyberbullying: Expert
11. More Americans Walking, But Still Not Enough, CDC Says
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2014)... Women in the Los Angeles area now ... future. The Independent Woman , a leader in ... upcoming Los Angeles area events. , These workshops ... from Kim Kiyosaki, a successful investor, entrepreneur, and bestselling ... passionate about women’s financial education. , Now, the Independent ...
(Date:7/31/2014)... (PRWEB) July 31, 2014 Transvaginal mesh ... continue to move forward in the federal multidistrict litigation ... Virginia, Bernstein Liebhard LLP reports. According to an Order ... consider certain defense motions now pending before the Court. ... Magistrate Judge on Tuesday, August 5th at 2:30 p.m. ...
(Date:7/31/2014)... York, New York (PRWEB) July 31, 2014 ... to grow, as Bernstein Liebhard LLP notes that ... that it plans to voluntarily remove its power ... to a report from Bloomberg.com, the company said ... and benefits associated with the devices remain uncertain.* ...
(Date:7/31/2014)... (PRWEB) July 31, 2014 Ticket Down ... Bolivia tickets at Dick’s Sporting Goods Park in suburban ... the Mexican national soccer team has found a second home ... failures during their time playing international friendly games and will ... at Dick’s Sporting Goods Park in Commerce City, Colorado. The ...
(Date:7/31/2014)... York, NY (PRWEB) July 31, 2014 ... http://www.biotechniques.com ) is now available as an open ... , P-LinK: A method for generating multicomponent ... chemistry for sensors , A workflow ... using high-throughput next-generation sequencing , Quantification ...
Breaking Medicine News(10 mins):Health News:The Independent Woman to Offer Financial Workshops in the Los Angeles Area - Developed by Women for Women 2Health News:Ethicon Transvaginal Mesh Lawsuits Move Forward, With Scheduling of Hearing in Federal Litigation, Bernstein Liebhard LLP Reports 2Health News:Ethicon Transvaginal Mesh Lawsuits Move Forward, With Scheduling of Hearing in Federal Litigation, Bernstein Liebhard LLP Reports 3Health News:Uterine Morcellation Controversy Grows, as Bernstein Liebhard LLP Notes Johnson & Johnson Decision to Withdraw Power Morcellators from Market 2Health News:Uterine Morcellation Controversy Grows, as Bernstein Liebhard LLP Notes Johnson & Johnson Decision to Withdraw Power Morcellators from Market 3Health News:Mexico vs. Bolivia Tickets at Dick’s Sporting Goods Park in Commerce City (Denver), CO Now Available at Ticket Down 2Health News:Mexico vs. Bolivia Tickets at Dick’s Sporting Goods Park in Commerce City (Denver), CO Now Available at Ticket Down 3Health News:BioTechniques: The International Journal of Life Science Methods Announces the Publication of the July 2014 Issue—Available in Print and Online as an Open Access Journal 2Health News:BioTechniques: The International Journal of Life Science Methods Announces the Publication of the July 2014 Issue—Available in Print and Online as an Open Access Journal 3
... global provider of corporate training software and solutions, has partnered ... healthcare training courses to CERTPOINTVLS™ users. , ... ... leading global provider of corporate training software and solutions, today ...
... Health Organization promotes awareness to a specific priority area of concern. ... ... issues arise from coordinating care to rights of health care workers. This ... safety practices and preparedness of health facilities and readiness of health workers ...
... provider of clinical supply chain management solutions to the health care ... announced today by William Zierolf, Chief Executive Officer of MHS. ... ... 2009 -- Management Health Solutions, Inc. (MHS) , a leading ...
... Management software to an assisted medical billing process providing the ... ... CT (Vocus) April 7, 2009 -- Glenwood Systems LLC announced today ... practice efficiencies and improve physician revenue in an office based medical ...
... 2009) The 2009 HealthGrades Patient Safety Excellence Award ... the leading independent healthcare ratings organization. These hospitals represent ... prevent errors at a higher rate than other U.S. ... level of Patient Safety Excellence Award hospitals, approximately 211,697 ...
... of chronic obstructive pulmonary disease (COPD), but it may ... cause exacerbations of the disease, according to new research ... established that smoking is the main risk factor for ... substantially changes the immune response to bacteria, which means ...
Cached Medicine News:Health News:CERTPOINT Systems Partners with Medcom Trainex, Inc. to Offer Extensive Library of Healthcare Courses -- Professionals in Healthcare sector to benefit from online educational courses 2Health News:CERTPOINT Systems Partners with Medcom Trainex, Inc. to Offer Extensive Library of Healthcare Courses -- Professionals in Healthcare sector to benefit from online educational courses 3Health News:CERTPOINT Systems Partners with Medcom Trainex, Inc. to Offer Extensive Library of Healthcare Courses -- Professionals in Healthcare sector to benefit from online educational courses 4Health News:Magazines.com Offers Professional Discounted Subscriptions to Healthcare Publications 2Health News:Management Health Solutions, Inc. Procures Key Funding from Eastward Capital Partners 2Health News:Glenwood Systems, LLC Releases EMR Practice Management and Medical Billing Process Improvement Program 2Health News:Glenwood Systems, LLC Releases EMR Practice Management and Medical Billing Process Improvement Program 3Health News:Study: Every 1.7 minutes a Medicare beneficiary experiences a patient safety event 2Health News:Study: Every 1.7 minutes a Medicare beneficiary experiences a patient safety event 3Health News:Cigarette smoke may alter immune response in COPD exacerbations 2Health News:Cigarette smoke may alter immune response in COPD exacerbations 3
(Date:7/31/2014)... 2014 Nektar Therapeutics (Nasdaq: NKTR ) ... June 30, 2014. Cash and investments in ... compared to $309.1 million at March 31, 2014."The second half ... we look forward to significant milestones for a number of ... Chief Executive Officer of Nektar. "The first of these is ...
(Date:7/31/2014)... , July 31, 2014 Rock Creek ... that it has initiated the development of its lead ... and that it has selected Quotient Clinical, The Translational ... (UK) to run its early development programs. ... Trial Application (CTA) by the end of the third ...
(Date:7/31/2014)... 2014 Touro University California,s College of Pharmacy ... the recipient of a $150,000 grant by the Joseph ... to increase research and classroom space on its campus. ... the study of health sciences, and will help us ... interests of our students," said Shelley Berkley , ...
Breaking Medicine Technology:Nektar Therapeutics Reports Financial Results for the Second Quarter of 2014 2Nektar Therapeutics Reports Financial Results for the Second Quarter of 2014 3Nektar Therapeutics Reports Financial Results for the Second Quarter of 2014 4Nektar Therapeutics Reports Financial Results for the Second Quarter of 2014 5Nektar Therapeutics Reports Financial Results for the Second Quarter of 2014 6Nektar Therapeutics Reports Financial Results for the Second Quarter of 2014 7Nektar Therapeutics Reports Financial Results for the Second Quarter of 2014 8Nektar Therapeutics Reports Financial Results for the Second Quarter of 2014 9Nektar Therapeutics Reports Financial Results for the Second Quarter of 2014 10Nektar Therapeutics Reports Financial Results for the Second Quarter of 2014 11Nektar Therapeutics Reports Financial Results for the Second Quarter of 2014 12Nektar Therapeutics Reports Financial Results for the Second Quarter of 2014 13Nektar Therapeutics Reports Financial Results for the Second Quarter of 2014 14Rock Creek Pharmaceuticals Provides Update of its European Drug Development Regulatory Strategy and selects Quotient Clinical for its early development programs 2Rock Creek Pharmaceuticals Provides Update of its European Drug Development Regulatory Strategy and selects Quotient Clinical for its early development programs 3Rock Creek Pharmaceuticals Provides Update of its European Drug Development Regulatory Strategy and selects Quotient Clinical for its early development programs 4Touro University California Garners Grant From Long Foundation 2
... OrbusNeich today announced that clinical trial results highlighting ... progenitor cell (EPC) capture technology across challenging patient subsets ... from Genous to Combo" at Transcatheter Cardiovascular Therapeutics (TCT) ... R stent is safe and effective in diabetic patients, ...
... CSL Plasma , one of the world,s largest collectors of ... as part of a statewide observance of "Plasma Protein Therapies ... President and General Manager of CSL Plasma, Plasma Protein ... diseases treated with plasma-derived therapies while recognizing the generous contributions ...
Cached Medicine Technology:Data from Multiple Clinical Trials of OrbusNeich's Genous™ Bio-engineered R Stent™ Demonstrate Safety and Effectiveness Across Challenging Patient Subsets as Presented at TCT 2010 2Data from Multiple Clinical Trials of OrbusNeich's Genous™ Bio-engineered R Stent™ Demonstrate Safety and Effectiveness Across Challenging Patient Subsets as Presented at TCT 2010 3Data from Multiple Clinical Trials of OrbusNeich's Genous™ Bio-engineered R Stent™ Demonstrate Safety and Effectiveness Across Challenging Patient Subsets as Presented at TCT 2010 4Duluth-Area Plasma Donors to be Recognized for Lifesaving Contribution in Fight Against Rare Diseases 2
Scoville-Haverfield Hemilaminectomy Retractor...
Bookwalter Spinal Retractor...
Circular Spine Retractor System for microsurgical interventions in the lumbar and cervical spine region....
Posterior Lumbar Retractor System ideally suited for spinal fixation, laminectomy, PLIF procedures. This system brings microdiscectomy to multi-level reconstruction....
Medicine Products: